TM Capital has developed in-depth health care sector expertise by completing the many transactions listed below for clients who are leaders across a range of health care disciplines.
MedTech Completes Recapitalization TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity
Dinex Acquired by Carlisle Companies TM Capital advised Dinex Holdings, a provider of specialty foodservice products, in its sale to Carlisle Companies (NYSE), a $2 billion diversified global manufacturing company
Immucor Forms Joint Venture with Kainos TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor's products in Japan with Kainos Laboratories, Inc.
Immucor Acquires Gamma Biologicals TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer
SteriGenics Acquired by IBA TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash
SteriGenics Acquires Nicolet from Thermo TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring Nicolet Electron Services from the Thermo-Electron Group (NYSE)
Portland Professional Acquired by NMHC TM Capital completed the sale of Portland Professional Pharmacy to National Medical Health Card Systems, Inc. (NASDAQ)
Heico Sells Meditek to U.S. Diagnostic Labs TM Capital completed the $23 million sale by Heico Corporation (NYSE) of its Meditek Health division to U.S. Diagnostic Labs, Inc. (NASDAQ)
Medical Diagnostics Acquired by ANMR TM Capital completed the $29 million sale of Medical Diagnostics, Inc. (NASDAQ) to Advanced NMR Systems Inc. (NASDAQ) following an unsolicited tender offer by Raytel Medical Corp. (NASDAQ)
Armstrong Pharma Acquired by Medeva TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
Immucor Acquires Division of Biopool TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)
Immucor Board of Directors Re-Elected TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor's directors were successfully re-elected
Immucor Goodwill Valuation Analysis TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142
BioLok Acquired by Healthpoint Capital TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital